Your doctor will do blood tests at least every 2 weeks for the first month and as needed during treatment with alecensa. Highlights of prescribing information cardiac dysfunction. Regorafenib is a monohydrate and it has a molecular formula c 21 h 15 c l f 4 n 4 o 3. This letter is to inform you of an important update. Refer to an fdaapproved test s package insert for instructions on the identification of patients eligible for treatment with xalkori. Severe and sometimes fatal hepatotoxicity has occurred in clinical trials. Page 6 of 37 haemorrhage throughout the iressa lung cancer clinical trials, the incidence of haemoptysispulmonary. Zerbaxa ceftolozane tazobactam for injection, for intravenous use. In patients who develop an acute onset of new or progressive pulmonary symptoms, such as dyspnea, cough or fever, treatment wit h tarceva should be. Prescribing information update for sutent sunitinib malate. Nexavar tablets are round, biconvex, red filmcoated tablets, debossed with the bayer cross on one side and 200 on the other side. Tagrisso osimertinib tablets, for oral use initial u.
Medlineplus information on ceritinib a lay language summary of important information about this drug that may include the following. Dose modifications for hepatotoxicity guidelines for dose adjustment of nerlynx in the event of liver toxicity are shown in table 5. Everyone living with a cancer diagnosis could use some support along the way. For important risk and use information about nexavar, please see the full prescribing information. Contact pfizer medical information to speak with a professional regarding your medical question on a pfizer prescription product. About dacomitinib dacomitinib is an oral, oncedaily, panher inhibitor. The product contains the identical amino acid sequence of isolated natural erythropoietin. Alecensa alectinib capsules, for oral use initial u. Filmcoated, red, oval shaped and debossed with w104 on one side and plain on the other side. Please click here for full prescribing information for lantus or scan qr code. Highlights of prescribing information consideration of the. The recommended dose of xalkori in patients with preexisting moderate hepatic impairment any aspartate aminotransferase ast and total bilirubin greater than 1. Highlights of prescribing information these highlights do not include all the information needed to use alecensa safely and effectively.
This insulin product shall not be used if it is not waterclear and colourless or if it has. Jakafi is indicated for treatment of intermediate or highrisk myelofibrosis mf, including primary mf, postpolycythemia vera mf and postessential thrombocythemia mf in adults. Hepatotoxicity see full prescribing information for complete boxed warning. For healthcare professionals nerlynx neratinib tablets.
Here you will find information and tools you need to stay informed and connected, including. Click select to convert the file into pdf format and insert it into the document. Highlights of prescribing information these highlights do not include all the information needed to use tarceva safely and effectively. Talk to your healthcare provider if this is a concern for you. Regorafenib is practically insoluble in water, slightly soluble in acetonitrile, methanol, ethanol, and ethyl acetate and sparingly soluble in acetone. Although pacritinib remains on full clinical hold, the fda recently indicated to cti biopharma they would allow patients who were receiving benefit from pacritinib treatment at the time the clinical hold was imposed to resume pacritinib treatment under a single patient ind spicompassionate use program.
As a single agent, for the extended adjuvant treatment of adult patients with earlystage her2positive breast cancer, to follow adjuvant trastuzumabbased therapy. Inlyta may cause fertility problems in males and females, which may affect your ability to have a child. Highlights of prescribing information these highlights. Muscle problems are common with alecensa and can be severe. Ridgefield, ct, july 12, 20 boehringer ingelheim pharmaceuticals, inc. Grade 3 diarrhea requiring iv fluid treatment or any signs or. Stivarga regorafenib can cause liver problems, which can be serious and sometimes lead to death.
Xalkori can cause fetal harm when administered to a pregnant woman based on its mechanism of action. Safety and efficacy of gilotrif were not established in patients whose tumors have resistant egfr mutations. In the pnet study, 183 patients 1% receiving sutent had grade 3 epistaxis, and no patients had other grade 3 or 4 bleeding events. Insert pdf file in latex document tex latex stack exchange. Refer to the pembrolizumab prescribing information for recommended pembrolizumab dosing information. Effect of prophylaxis or neratinib dose escalation on neratinib related diarrhea and tolerability in patients with her2positive earlystage breast cancer. Therefore, colestid resin may delay or reduce the absorption of concomitant oral medication. Since colestid is an anionexchange resin, it may have a strong affinity for anions other than the bile acids. When administering lenvima in combination with everolimus for the treatment of renal cell carcinoma, reduce the lenvima dose first and then the everolimus dose for adverse reactions of both lenvima and everolimus. Refer to the everolimus prescribing information for additional dose modification information. Treatment should continue until disease progression or unacceptable toxicity occurs. Inlyta is indicated for the treatment of advanced renal cell carcinoma rcc after failure of one prior systemic therapy.
Definition from the nci drug dictionary detailed scientific definition and other names for this drug. Refer to an fdaapproved tests package insert for instructions on the identification of patients eligible for treatment with xalkori. Table 2 lists the recommended dosage reductions of. Ceritinib is also being studied in the treatment of other types of cancer. Inlyta axitinib fdaapproved patient labeling pfizer.
How to add and organize pages in a pdf adobe acrobat dc tutorials. Highlights of prescribing information these highlights do. Highlights of prescribing information embolism pe can. Your healthcare provider will do blood tests to check your liver function before you start taking stivarga and during your treatment with stivarga to check for liver problems.
In vitro studies have indicated that colestid binds a number of drugs. Product information colestid colestipol hydrochloride. Oct 18, 2019 gilotrif is a kinase inhibitor indicated for. Highlights of prescribing information these highlights do not include all the information needed to use tagrisso. See full prescribing information for complete boxed warning. The pdfpages package makes it easy to insert pages of external pdf. Learn where nerlynx plays a role in your treatment plan, sign up for email updates, and download faqs about nerlynx. Inlyta axitinib tablets 2ndline mrcc treatment safety. Nerlynx neratinib tablets, for oral use indications and usage. Because of the potential for serious adverse reactions in a breastfed child from nexavar, advise lactating women not to breastfeed during treatment with nexavar and for 2 weeks after the last dose.
Highlights of prescribing information these highlights do not include all the information needed to use sutent safely and effectively. Learn about the indications for sutent sunitinib malate on the official patient website. Nerlynx as a single agent is indicated for the extended adjuvant treatment of adult patients with earlystage. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Epogen is formulated as a sterile, colorless liquid in an isotonic. Highlights of prescribing information patients at risk of. Food and drug administration fda has approved gilotrif tm afatinib tablets for oral use, as a new firstline initial treatment for patients with metastatic nonsmall cell lung cancer nsclc with common epidermal growth factor receptor egfr mutations as detected by an fdaapproved.
Tell your healthcare provider about all the medicines you take, including prescription and overthecounter medicines, vitamins, and herbal supplements. Pfizer oncology is committed to providing you with uptodate information about sutent sunitinib malate capsules. Product monograph lantus insulin glargine injection. Dose increase or reduction is recommended based on individual safety and tolerability. Tablets containing sorafenib tosylate 274 mg equivalent to 200 mg of sorafenib. Dec 16, 2019 tecentriq atezolizumab injection for intravenous infusion is a monoclonal antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma cancer who have disease progression during or following platinumcontaining chemotherapy, or have disease progression within 12 months of neoadjuvant or adjuvant. Over the course of treatment, patients who tolerate inlyta for at least two consecutive weeks with no adverse reactions grade 2 according to the common toxicity criteria for adverse events ctcae, are normotensive, and are not receiving antihypertension medication, may.
1427 1280 449 720 1226 238 464 1032 917 1572 1195 841 1398 1220 1549 110 1166 1411 962 857 5 1327 1035 816 1167 713 935 1314 467 1006 981 1300 876 1546 94 466 62 1388 872 1073 1499 1480 466